The rise of personalised medicine, which is mainly based on genetic testing, needs adequate regulation so privacy rights aren’t breached. That’s only one of several issues that must be considered.
Articles on Genomic sequencing
Displaying 21 - 23 of 23 articles
A new study has identified that pancreatic cancer is not one, but four types of cancer, and opened the door to possible new treatments.
Personalised medicine is based on the idea that by understanding the specific molecular code of a person’s disease, and particularly its genetic makeup, we can more accurately tailor treatment.
Top contributors
-
Professor of Breast Cancer Research, Institute of Health and Biomedical Innovation and School of Biomedical Sciences,, Queensland University of Technology
-
Adjunct Research Scientist in Marine Bioscience, University of Florida
-
Bertalli Chair in Cancer Medicine and Director of Research for the Centre for Cancer Research, The University of Melbourne
-
Researcher in the Division of Molecular Biology and Human Genetics, Stellenbosch University
-
Professor, Faculty of Law, University of Technology Sydney
-
Professor of Environmental Genomics, Curtin University
-
Specialist Scientist, Tuberculosis Host Genetics, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University
-
Professor, Central Clinical School, Monash University
-
Emeritus Professor of Law, University of Tasmania
-
Associate Professor, School of Biomedical Sciences, Queensland University of Technology
-
Head of the Clinical Unit of Medical Genetics and Genetic Counselling, Stellenbosch University
-
Leader, Environomics Future Science Platform, CSIRO
-
Specialist Rheumatologist, Senior Lecturer in Paediatrics and Child Health, Stellenbosch University
-
Professor in the Division of Molecular Biology and Human Genetics in Department of Biomedical Sciences, Stellenbosch University
-
Honarary Professor in Environmental Genomics, University of Otago